| | | DAA initiators | DAA Initiators (by clinical trials) | Did not receive DAAs | | | |
| | Women (%) | 7 (16) | 4 (17) | 212 (30) | | Aboriginal (%) | 2 (5) | 4 (17) | 174 (25) | | Income <$1500/month (%) | 30 (70) | 12 (52) | 537 (76) | | Injection drug use (last 6 months) (%) | 2 (5) | 5 (22) | 249 (35) | | Alcohol Use (%) | 3 (8) | 1 (4) | 132 (22) | | CD4 T Count (cells/mL) median, IQR | 460 (290, 754) | 460 (360, 620) | 470 (290, 670) | | APRI >1.5 (%) | 12 (28) | 2 (10) | 139 (20) | | HIV Combined Antiretroviral therapy | 40 (93) | 21 (91) | 594 (84) |
|
|
